Tobin W Juvenal sold $527K of Castle Biosciences (CSTL)

Executed Mar 12, disclosed Mar 16, 4 days later.

Value, as filed

$527K

20,863 sh × $25.24

Executed

Mar 12

the trade date, as filed

Disclosed

Mar 16

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Tobin W Juvenal Chief Commercial Officer profile →

Tobin W Juvenal (Chief Commercial Officer) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in Castle Biosciences, Inc. (CSTL). The largest single filing was $527K of CSTL (20,863 sh × $25.24, as filed), executed Mar 12.

The name

CSTL

Castle Biosciences, Inc. CSTL · Healthcare · 53 filings in 24 months ticker →

Healthcare · Castle Biosciences, Inc., a molecular diagnostics company, provides test solutions for the diagnosis and treatment of dermatologic cancers,…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Tobin W Juvenal in CSTL

CSTLSALE Castle Biosciences, Inc. $223K
6,600 sh across 2 lots
Exec Sep 14
Filed Sep 16 · 4:20 PM ET CSTLSALE Castle Biosciences, Inc. $317K
9,050 sh × $35.04
Exec Aug 25
Filed Aug 27 · 4:38 PM ET CSTLSALE Castle Biosciences, Inc. $450K
15,419 sh across 2 lots
Exec Jul 31
Filed Aug 4 · 4:36 PM ET CSTLSALE Castle Biosciences, Inc. $495K
13,200 sh × $37.48
Exec Dec 11 2025
Filed Dec 15 2025 · 5:30 PM ET CSTLSALE Castle Biosciences, Inc. $167K
4,693 sh × $35.58
Exec Nov 20 2025
Filed Nov 24 2025 · 5:30 PM ET CSTLSALE Castle Biosciences, Inc. $125K
3,507 sh × $35.56
Exec Nov 5 2024
Filed Nov 7 2024 · 5:30 PM ET CSTLSALE Castle Biosciences, Inc. $110K
3,100 sh × $35.39
Exec Nov 1 2024
Filed Nov 5 2024 · 5:30 PM ET